BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells.
about
A Novel Epi-drug Therapy Based on the Suppression of BET Family Epigenetic Readers.BRD4 inhibition for the treatment of pathological organ fibrosisNovel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells.JQ1 synergizes with the Bcl-2 inhibitor ABT-263 against MYCN-amplified small cell lung cancer.Targeting cistrome and dysregulated transcriptome of post-MPN sAML.SOHO State-of-the-Art Update and Next Questions: MPN.Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts.BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against mantle cell lymphoma cells.Ruxolitinib synergistically enhances the anti-tumor activity of paclitaxel in human ovarian cancer.The Emerging Spectrum of Early Life Exposure-Related Inflammation and Epigenetic Therapy
P2860
Q39207675-890F386C-B128-4F7E-94FC-D48129BD6D22Q39442981-4D673DE9-1F93-4A62-ACA4-5A30D0408BE8Q41190385-DF90D3B1-9542-4762-A9A9-E7ACE237E194Q44268034-10BB9D98-6C3D-4D5E-886D-DE0170A94399Q49344267-CE07858C-A621-49F6-BCFB-92981D89A64FQ49580473-A7CA7137-7AAF-4F88-83FA-7EDFEF7152ABQ49830905-D148B70C-BCB9-4274-9079-36939707E68BQ50433449-4DDEA146-09A1-435B-8F46-0DA2E5FEEC09Q55084775-6E14752D-C4C4-4F99-B2DD-5D36E9D75022Q59125138-D669969F-3624-44C2-B0CF-46FA39D40F3E
P2860
BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
BET protein bromodomain inhibi ...... neoplasm secondary AML cells.
@en
BET protein bromodomain inhibi ...... neoplasm secondary AML cells.
@nl
type
label
BET protein bromodomain inhibi ...... neoplasm secondary AML cells.
@en
BET protein bromodomain inhibi ...... neoplasm secondary AML cells.
@nl
prefLabel
BET protein bromodomain inhibi ...... neoplasm secondary AML cells.
@en
BET protein bromodomain inhibi ...... neoplasm secondary AML cells.
@nl
P2093
P2860
P356
P1433
P1476
BET protein bromodomain inhibi ...... neoplasm secondary AML cells.
@en
P2093
Baohua Sun
Christopher P Mill
Courtney DiNardo
Cristian Coarfa
Dyana T Saenz
Kapil N Bhalla
Kimal Rajapakshe
Naveen Pemmaraju
Simrit Parmar
P2860
P2888
P304
P356
10.1038/LEU.2016.260
P577
2016-09-28T00:00:00Z